NuvoAir Home provides you with real insights about how your respiratory health develops over time. It helps you manage your respiratory condition and take the most effective medical decisions in synergy with your physician. NuvoAir Home is the right choice for patients with respiratory conditions such as Asthma, COPD, Cystic Fibrosis, IPF or patients with lung transplant. NuvoAir Home is powered by Air Next, an award-winning professional spirometer designed for home use. Key features -Personal insights of your lung health trends. -Measure total lung volume, first second volume, peak flow and ratio via Air Next -Air quality in your area. -Medication tracking. -Symptoms tracking. -Personal diary. -Activity. -Monthly insights. Your data can be automatically shared with your healthcare provider. In addition to this app, seek doctor's advice before making any medical decisions. NuvoAir Home is not intended for diagnostic purposes. The Air Next Spirometer -It connects automatically and wirelessly to your mobile device via Bluetooth. -It is maintenance free thanks to the hygienic and high precision disposable turbine. No need for sterilisation and calibration. -The Air Next spirometer is as accurate as a professional spirometer, but costs a fraction of it. The Air Next It is required to be able to perform spirometry tests with NuvoAir Home. Find out more at www.nuvoair.com Technical info The app connects with Health App from Apple, so you can export spirometer data (FVC, FEV1, PEF) from the Air app to the Health App. The app shows expected test results, predicted by height, age, gender and ethnicity. The Air Next is intended to measure the forced expiratory volume in 1 second (FEV1), the peak expiratory flow (PEF) and the forced vital capacity (FVC) in a forced expiratory maneuver. These measures can be used for the detection, assessment and monitoring of certain lung diseases. NuvoAir Home is CE Certified as a Class Im Medical Device. NuvoAir is ISO 13485 certified. NuvoAir Home home is registered or cleared for sale in the United States, European Union and South Africa and may be legally distributed for use in clinical research trials outside these jurisdictions.
Show Less
